Mallinckrodt Pharmaceuticals combined with Endo in 2025 to better serve customers and improve outcomes for the patients we support. From this union, we established two focused, standalone companies: – Keenova Therapeutics, a branded therapeutics business – Par Health, a generics and sterile injectables business To learn more, follow Keenova and Par Health on LinkedIn and visit keenova.com and parhealth.com.
Looking for a particular Mallinckrodt Pharmaceuticals employee's phone or email?
The Mallinckrodt Pharmaceuticals annual revenue was $243 million in 2026.
Andrew Gonce is the Vice President Commercial and Strategy of Mallinckrodt Pharmaceuticals.
2,273 people are employed at Mallinckrodt Pharmaceuticals.
Mallinckrodt Pharmaceuticals is based in Dublin, Leinster.
The NAICS codes for Mallinckrodt Pharmaceuticals are [325, 32, 32541, 3254].
The SIC codes for Mallinckrodt Pharmaceuticals are [28, 283].